FDA Approved: MAYZENT — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Mayzent (siponimod) filed by Novartis Pharmaceuticals Corporation. The action updates the drug's labeling under …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• MAYZENT (siponimod)

Snippet

SUPPL AP for MAYZENT (SIPONIMOD)